Abstract
Background: The purpose of the study is to evaluate the prescribing pattern of drugs used in the management of hypertension in a tertiary care teaching hospital
Methods: A prospective study was conducted for the period of 5 months in an out-patient department. Prescription of males and females with diagnosed primary essential hypertension as per (JNC-VIII guidelines and patients receiving or prescribed with antihypertensive drugs were included. The collected was analyzed for the demographic profile of the patients and the prescribing pattern of antihypertensive drugs used in the management of hypertension.
Results: A total of 200 prescriptions were evaluated during study period, 51% were male and 49% were females respectively. Mean age of males and females was 52.7±1.3 and 48.03±0.4 years respectively. Dual therapy (61%) followed by monotherapy (20.5%) and multidrug therapy (18.5%) was prescribed to hypertensive patients. ARB+Diuretics (33.6%) followed by ARB+beta blocker (17.2%), ARB+CCB (17.2%) and ACEI+Diuretic (9.8%) were used in dual therapy. Angiotensin receptor blockers (44.73%) are most widely prescribed drugs followed by CCB (21.05%), ACEIs (14.6%), Diuretics (10.52%) and Beta blockers (10.52%) in monotherapy. In triple drug therapy most common combination was Diuretic+ARB+ACEIs (18.91%) and ARB+Beta blocker+CCB (18.91%). Single drug therapy ARB reduced SBP by 18.5% and DBP by 12.5% and in dual therapy combination of ARB and beta blocker reduced SBP by 22.16% & CCB+ACEI reduced DBP by 19.31%.
Conclusions: Dual therapy was frequently prescribed regimen followed by multidrug and monotherpy. ARB+Diuretic was most preferred treatment. In monotherapy most preferred drug was ARB followed by CCB. The prescribing patterns of anti HT drugs moderately followed standard treatment as per international guidelines for hypertension
Keywords: Prescription, Antihypertensives, Blood pressure, JNC-VII, Prescription pattern.
References
- Franklin SS, Gustin W, 4th, Wong ND, Larson MG, Weber MA, Kannel WB, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham heart study. Circulation. 1997;96:308–15.
- Harrison-Bernard LM, Raij L. Postmenopausal hypertension. Curr Hypertens Rep. 2000;2:202–7.
- A global brief on hypertension: Silent killer, global public health crisis. WHO/DCO/WHD/2013.2. http://www.who.int/cardiovascular_diseases/publications/global_brief_hypertension/en/. Accessed 11th Dec 2019.
- Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455): 217-23.
- Gupta R. Trends in hypertension epidemiology in India.J Hum Hypertens. 2004 ;Feb;18(2):73-8.
- Causes of Death 2008 [online database]. Geneva, World Health Organization. http ://www.who.int/healthinfo/global_burden_disease/cod_2008_sources_methods.pdf.Accessed 14th Dec 2019.
- Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380 (9859):2224-60.
- Shrank WH, hoang T, Ettner SL, etal. The implications of choice: prescribing generic or preffered pharmaceuticals improves medication adherence for chronic conditions. Arch intern Med. 2006;166(3):332-337.
- Sepehri G, Talebizadeh N, Mirzazadeh A,Mohsenbeigi M. The patterns of antihypertensive drug prescription by cardiologists in Kerman province of Iran, 2006. Pharmacoepidemiol Drug Saf. 2008;17:180-5.
- Chiang CW, Chen CY, Chiu HF, Wu HL, Yang CY. Trends in the use of antihypertensive drugs by outpatients with diabetes in Taiwan, 1997-2003. Pharmacoepidemiol Drug Saf. 2007;16:412-21.
- James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507-20.
- Yuen YH, Chang S, Chong CK, Lee SC, Critchlev JA, Chan JC. Drug utilization in a hospital general medical outpatient clinic with particular reference to antihypertensive and antidiabetic drugs. J Clin Pharm Ther 1998; 23:287-94.
- Tiwari H, Kumar A, Kulkarni SK. Prescription monitoring of antihypertensive drug utilization at the Punjab University Health Centre in India. Singapore Med J. 2004;45(3):117-20.
- Dipiro JT, Talbert RL, Yee GC, Wells BG, Posey LM. Pharmacotherapy A Pathophysiologic Approach. Seventh edition, 2008, McGraw-Hill Medical, New York, United States of America. 2008.
- Tasneem S, Vamsi Krishna E. Survey of prescription pattern of anti-hypertensive drugs in hypertensives and hypertension associated diabetics. Int J Pharma Bio Sci. 2010;1(4):23-6.
- Preethi GP, Jnaneshwara S, Narendranath S. Prescribing patterns of antihypertensive drugs in a South Indian tertiary International Journal of Basic & Clinical Pharmacology | March-April 2014 | Vol 3 | Issue 2 Page 307 care hospital. Drug Invent Today. 2011;3(4):38-40.
- Jackson JH, Sobolski J, Krienke R, Wong KS, Frech- Tamas F, Nightengale B. Blood pressure control and pharmacotherapy patterns in the United States before and after the release of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7)guidelines. J Am Board Fam Med. 2008;21(6):512-21.
- Jhaj R, Goel NK, Gautam CS, Hota D, Sangeeta B, et al. Prescribing patterns and cost of antihypertensive drugs in an internal medicine clinic. Ind. Heart J. 2001;53:323-7.
- Malhotra S, Karan R, Pandhi P, Jain S. Pattern of use and pharmacoeconomic impact of antihypertensive drugs in a North Indian referral hospital. Eur J Clin Pharmacol. 2001;57:535-40.
- Kothari N, Ganguly B. Adherence to JNC-VII and WHO-ISH guidelines of antihypertensive medications prescribed to hypertensive patients with co-morbid conditions. Indian J Physiol Pharmacol. 2015;59(1):48-56.
- Murti K, Khan MA, Dey A, Sethi MK, Das P, Pandey K. Prescription Pattern of Anti-Hypertensive Drugs in Adherence to JNC- 7 Guidelines. American Journal of Pharmacology and Toxicology. 2015;10(1):27-31.
- Pittrow D, Kirch W, Bramlage P, Lehnert H, Höfler M, et al.. Patterns of antihypertensive drug utilization in primary care. Eur J Clin Pharmacol. 2004;60:135-42.
- Lee PK, Li RK, Chan JC, Chang S, Lee SC, Tomlinson B, Critchley JA. A prescription survey in a hospital hypertension outpatient clinic. Br J Clin Pharmacol. 1997;44(6):577-82.
- Cidda M, Mateli UV, Batchu MK, Maratha S. Study of prescribing patterns of anti hypertensives in south Indian population. Int J Basic Clin Pharmacol 2014;3:303-7
- Romday R, Gupta AK, Bhambani P. Assessment of antihypertensive drug prescription patterns and adherence to joint national committee-8 hypertension treatment guidelines among hypertensive patients attending a tertiary care teaching hospital. Int J Res Med Sci 2016;4:5125-33.
- Amira CO, Okubadejo NU. Antihypertensive pharmacotherapy in a developing economy: pattern, acquisition costs and conformity to international guidelines in a tertiary-care setting. Journal of Human Hypertension. 2006;20:894-7.
- World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens. 1999; 17:151-83.
- Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289:2560-72.
- Chalmers J. The ABCD of anti-hypertensive therapy. J Hypertens. 2002; 20:615-6.
- Jun M, Lee KV, Randall SS. Changes in antihypertensive prescribing during US outpatient visits for uncomplicated hypertension between 1993 and 2004. Hypertension. 2006;48:846-52.
- Fischer MA, Avorn J. Economic implications of evidence based prescribing for hypertension: can better care cost less? JAMA. 2004;291(15):1850-6.
- Dhanaraj E, Raval A, Yadav R, Bhansali A, Tiwari P. Prescription pattern of antihypertensive agents in T2DM patients visiting tertiary care centre in North India. Int J Hypertens. 2012;2012:520915.
Corresponding Author
Dr Apoorva Malhotra
Demonstrator, Department of Pharmacology, Acharya Shri Chander College of Medical Sciences & Hospital, Sidhra, Jammu, J&K 180017, India